oncology
FDA Approves Monjuvi for Relapsed or Refractory Follicular Lymphoma
The FDA approved Monjuvi with lenalidomide and rituximab for adults with relapsed or refractory follicular ...
JUNE 20, 2025
Integrative Medicine Pharmacists Help Drive Dietary Supplement Safety
Integrative medicine teams at cancer centers such as New York City’s Memorial Sloan Kettering Cancer ...
JUNE 13, 2025
Topical Gel Relieves Painful Rash Caused by Anti-EGFR Therapies
A novel topical gel significantly reduced the severity of the acne-like rash, a common side effect of ...
JUNE 13, 2025
Meeting the Toxicity Challenge Posed by Antibody–Drug Conjugates
Antibody–drug conjugates have yielded improved survival rates in patients with gynecologic malignancies, but ...
JUNE 13, 2025
Amid FDA Approval Gap, Cancer-Related Cachexia Treatment Guidelines Can Help
Approximately 80% of patients with advanced cancer experience cachexia, with a one-year mortality rate of 20% to ...
MAY 29, 2025
Filling the Malnutrition Screening Gap in Ambulatory Cancer Clinics
More malnutrition tests are needed in the outpatient oncology setting to improve patient outcomes, experts noted ...
MAY 29, 2025
Early Real-World Data Positive for NMIBC Immunotherapy
The first real-world outcomes data for nadofaragene firadenovec in patients with BCG-unresponsive ...
MAY 24, 2025
Automated Follow-up Alerts Pharmacists to Cancer Patients’ Needs
Early automated follow-up of cancer patients can help pharmacists more efficiently manage side effects of oral ...
MAY 18, 2025
FDA Approves Penpulimab for Non-Keratinizing Nasopharyngeal Carcinoma
The FDA has approved penpulimab-kcqx with cisplatin or carboplatin and gemcitabine for the first-line treatment of ...
MAY 9, 2025
Teledermoscopy Adds a Dose of Health Equity to Skin Cancer
Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as ...
APRIL 26, 2025
Pharmacists Play Important Role in Melanoma Education
Counseling survivors of melanoma on sun protection and skin health is an important role for pharmacists.
APRIL 25, 2025
Nivolumab Scores in Bladder and Renal Cancer Trials
Providing adjuvant nivolumab after radical resection continues to yield clinically meaningful disease-free survival ...
APRIL 10, 2025
